baber/WOPTO huggingface dataset:
Patent CA-2652616-A1 (CA)
Title: Drilling rod retainer
Inventor: JONES JERRY
IPC: E21B19/02
Filed: 2008-12-05
Abstract: A drilling rod retainer which effects safe handling of a drilling rod substantially independently of any auxilliary power equipment. The rod retainer is designed for placement on a drilling rig and support frame, and has two retaining arcuate arms which are biased, through use of at least one high tension spring connected between each of the arms, to substantially surround the drilling rod, when the retainer is in a normally closed position. The retaining arms have integrally connected flange portions that extend downwardly below the arms in order to provide additional surface area to hold and secure the drill rods as they are being removed from the down hole well.
Patent CA-2653311-A1 (CA)
Title: Injection device with syringe carrier engagement with cap
Inventor: BRADY MATTHEW JAMES
IPC: A61M5/20
Filed: 2007-05-29
Abstract: An injection device (110) is described having a housing (112) that receives a syringe (114) having a needle (118), wherein the syringe is supported in a syringe carrier (150). The injection device (110) has a removable cap (190). The syringe (114) and syringe carrier (150) are biased by a return spring (126) from an extended position in which the needle (118) extends from the housing (112) through an exit aperture (128) to a retracted position in which it does not. The syringe carrier (150) abuts a surface inside the removable cap (190) which prevents forward movement of the syringe carrier (150) when the cap is in place. The injection device is less prone to failure than prior art devices and is safer should failure occur.
Patent CA-2655398-A1 (CA)
Title: 4-amino-3-(3-azolyl-phenoxymethyl)-thieno[3,2-c]pyridine-7-carboxylic acid derivatives and uses thereof for treating cancer, atherosclerosis and restenosis
Inventor: CHEN YI
IPC: A61P35/00
Filed: 2007-06-22
Abstract: There are provided compounds of the formula (I) wherein R1 , R2 , R3 , X, ring A and ring B are as described. The compounds exhibit anticancer properties.
Patent CA-2659887-A1 (CA)
Title: Tampon applicator fingergrip having one or more flared portions
Inventor: JORGENSEN ROBERT
IPC: A61F13/20
Filed: 2007-08-03
Abstract: A tampon applicator assembly (10) having a barrel ( 12) with a fingergrip (18). The fingergrip (18) has one or more flared portions (20) and/or one or more ring-like or ring-like gripping structures (34). As a result of these features, the tampon assembly provides a user with increased control, which results in proper tampon placement and thus comfort to the user.
Patent CA-2659914-A1 (CA)
Inventor: GITLIN ISAAK GRIGORIEVICH
IPC: A61K9/20
Filed: 2007-07-27
Abstract: The invention relates to the pharmaceutical industry and to medicine, in particular to a novel highly active antioxidant which is used for preventing and treating diseases caused by oxidative stress and scarcity of oxygen in an organism and which is embodied in the form of a complex of a metal cation selected form an iron, copper, zinc and manganese group with rutin and cevitamic acid and/or dihydrocevitamic acid of general formula (I): emRu(AA)r(DGAA)p~Xn.(I). A method for producing a granulate containing said complex and the tableted and encapsulated form based thereon are also disclosed.
Patent CA-2660427-A1 (CA)
Inventor: NOMURA YUKIHIRO
IPC: A61K31/4245
Filed: 2007-08-09
Abstract: Disclosed is a solid pharmaceutical composition containing a low-melting-point oil/fat-like substance, which is improved in drug eluting property and has excellent stability and dissolution property. Specifically, disclosed is a solid pharmaceutical composition comprising a pharmacologically active ingredient, a low-melting-point oil/fat-like substance and a low-viscosity binder. Also disclosed is a method for improving the elution of a pharmacologically active ingredient from a solid pharmaceutical composition comprising the pharmacologically active ingredient and a low-melting-point oil/fat-like substance, characterized by using a low-viscosity binder.
Patent CA-2661843-A1 (CA)
Inventor: DUNN CHARLES S
IPC: A41D31/00
Filed: 2007-08-30
Abstract: Unique blends of fibers that incorporate synthetic cellulosic fibers to render fabrics made with such blends more durable than fabrics made with natural cellulosic fibers such as cotton. While more durable than cotton, the synthetic cellulosic fibers used in the blends are still inexpensive and comfortable to the wearer. Thus, the benefits of cotton (affordability and comfort) are still attained while a drawback of cotton - low durability - is avoided. In one embodiment, the fiber blend includes FR modacrylic fibers and synthetic cellulosic fibers, preferably, but not necessarily non-FR lyocell fibers such as TENCEL~ and TENCEL A100~. Other fibers may be added to the blend, including, but not limited to, additional types of inherently FR fibers, anti-static fibers, anti-microbial fibers, stretch fibers, and/or high tenacity fibers. The fiber blends disclosed herein may be used to form various types of FR fabrics. Desired colors may be imparted in a variety of ways and with a variety of dyes to the fabrics disclosed herein. Fabrics having the fibers blends disclosed herein can be used to construct the entirety of, or various portions of, a variety of protective garments for protecting the wearer against electrical arc flash and flames, including, but not limited to, coveralls, jumpsuits, shirts, jackets, vests, and trousers.
Patent CA-2663243-A1 (CA)
Title: Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use
Inventor: AURRAND-LIONS MICHEL
IPC: C07K16/28
Filed: 2007-09-28
Abstract: The present invention relates to the use of a compound that specifically binds to Junctional Adhesion Molecule -C (JAM-C) or -B (JAM-B) for the treatment of gliomas. More specifically the invention relates to the use of an antagonist of JAM-B or JAM-C for the treatment of glioma, in particular astrocytoma.
Patent CA-2666345-A1 (CA)
Title: Stain-masking cut resistant fabrics and articles and processes for making same
Inventor: PRICKETT LARRY JOHN
IPC: A41D31/00
Filed: 2007-10-09
Abstract: This invention relates to a stain-masking cut resistant fabrics and articles including gloves and methods for making articles, the fabrics and articles comprising a yarn (4) comprising an intimate blend of staple fibers, the blend comprising 20 to 50 parts' by weight of a lubricating fiber (8), 20 to 40 parts by weight of a first aramid fiber (5) having a linear density of. from 3.3 to 6 denier per filament (3.7 to 6.7 dtex per filament), 20 to 40 parts by weight of a second aramid fiber, (6) having a linear density of from 0.50 to 4.5 denier per filament (0..56 to 5 : 0 dtex per filament), and 2 to 15 parts by weight of a third aramid fiber (7) having a linear density of from 0.5 to 2.25 denier per filament (0.56 to 2.5 dtex per filament), based on the total weight of the lubricating and first, second and third aramid fibers. The difference in filament linear density of the first aramid fiber to the second aramid fiber is 1 denier per filament (1.1 dtex per filament) or greater, and the third aramid fiber is provided with a color different from that of the first or second aramid fibers.
Patent CA-2666469-A1 (CA)
Title: Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system
Inventor: KELDENICH JOERG
IPC: C07D307/82
Filed: 2007-08-28
Abstract: The present invention relates to benzofuran and benzothiophene derivatives and compositions containing such compounds for the production of medicaments for the treatment of cancers of the central nervous system as monotherapy or combination with other agents.
Patent CA-2669675-A1 (CA)
Title: Combination of er.alpha.+ ligands and histone deacetylase inhibitors for the treatment of cancer
Inventor: ORDENTLICH PETER
IPC: A61P35/00
Filed: 2007-11-09
Abstract: The present embodiments relate to compositions and methods of treatment of cancer. More particularly, the present embodiments relate to the combination of an ER.alpha.+ ligand with an HDACi for the treatment of cancer, methods of treating cancer and pharmaceutical compositions for treating cancer.
Patent CA-2669957-A1 (CA)
Title: Absorptive article
Inventor: TSUJI TOMOKO
IPC: A61F13/514
Filed: 2007-11-26
Abstract: An absorptive article less likely to have a bend at a leg portion. The absorptive article (1) has an elongate absorption member (2) having a lateral direction and a longitudinal direction perpendicular to the lateral direction and placed in the longitudinal direction, and the absorptive article (1) also has a stretchable chassis (3) having leg portions (3a) provided on both sides in the lateral direction so as to be recessed inward in the lateral direction. The entire portion or a portion of the chassis (3) is constructed from a composite sheet (13) formed by adhering to each other a stretchable sheet (15) and a non-stretchable sheet (16) by using adhesion sections (18). Each leg portion (3a) has an intersection portion intersecting with the stretch direction of the chassis (3) at a predetermined angle. The adhesion sections (18) are formed so as to extend in the intersection portion at predetermined intervals, extending in the direction substantially perpendicular to the stretch direction.
Patent CA-2672114-A1 (CA)
Inventor: KLAR ULRICH
IPC: A61P19/10
Filed: 2007-12-05
Abstract: The present invention relates to the use of natural or synthetic Epothilones for the treatment prevention or alleviation of diseases caused by a dysbalance of osteoclast and osteoblast activity, especially osteoporosis.
Patent CA-2673029-A1 (CA)
Title: Materiaux et procedes pour la generation de transcrits comprenant des nucleotides modifies
Inventor: KEEFE ANTHONY DOMINIC
IPC: C12P19/34
Filed: 2007-12-28
Abstract: L'invention concerne des matériaux et des procédés pour la production d'agents thérapeutiques à base d'aptamères comprenant des nucléotides triphosphates modifiés incorporés dans leur séquence.
Patent CA-2673180-A1 (CA)
Title: Procede et appareil destine a gonfler et degonfler des catheters a ballonet
Inventor: ABBOUD MARWAN
IPC: A61F2/958
Filed: 2007-09-20
Abstract: L'objet de la présente invention concerne un système et un procédé de contrôle du gonflage, du retrait et du dégonflage d'un cathéter à ballonet. Ce système comprend un cathéter à ballonet, une console, une source de gonflage au gaz ou au liquide sous pression ainsi qu'un système ombilical qui ammène l'agent de refroidissement sous pression au cathéter à ballonet. Le système peut comprendre un régulateur qui surveille la pression et le volume dans le cathéter à ballonet. Au cours du gonflage on maintient la pression et/ou le volume du fluide dans le ballonet à une valeur cible afin d'obtenir une pression mécanique suffisante sur la région cible désirée. Le système limite la pression de gonflage, de sorte qu'une certaine quantité de gaz serait libérée en cas de fuite. En cas de baisse en-deçà d'un certain seuil, l'échappement de gaz ou de liquide est supposé et le processus de gonflage est stoppé.
Patent CA-2673432-A1 (CA)
Title: Detection de motifs de reaction de cellule t individuelle contre des antigenes associes a une tumeur chez les patients atteints d'une tumeur comme base de vaccination therapeutique personnalisee des patients
Inventor: FATHO MARTINA
IPC: G01N33/50
Filed: 2007-11-28
Abstract: L'invention concerne un procédé d'identification des antigènes cibles préférentiels de cellules T anti-tumorales d'un patient atteint d'une tumeur, comprenant : a) la mise à disposition de cellules T provenant du sang d'au moins un patient atteint d'une tumeur ; b) la mise à disposition de cellules dendritiques (CDs) et/ou de lymphocytes B (LCBs) autologues du patient atteint d'une tumeur, sachant que les CDs et les LCBs ont été préalablement transfectés avec une sélection d'ARNm qui codent des antigènes tumoraux (TAA) immunogènes aux cellules T et les expriment ; c) mise en contact des cellules T avec les CDs et/ou les LCBs ; d) identification des cellules T qui reconnaissent les antigènes des CDs et/ou des LCBs ; et e) identification des antigènes cibles préférentiels de cellules T anti-tumorales du patient au moins unique atteint d'une tumeur sur la base des cellules T qui reconnaissent les antigènes des CDs et/ou des LCBs. Le procédé peut en outre comprendre l'expansion des cellules T qui reconnaissent les antigènes des CDs et/ou des LCBs. L'invention concerne en outre un procédé de production d'un vaccin tumoral individualisé ou d'une thérapie tumorale individualisée, ainsi que des procédés correspondants de traitement d'une maladie tumorale en utilisant le vaccin tumoral individualisé ou la thérapie tumorale individualisée.
Patent CA-2674004-A1 (CA)
Title: Container
Inventor: HOOK WILLIAM J
IPC: B65D51/24
Filed: 2007-12-26
Abstract: A container (210) for holding granular or powdered mate.pi.al and formed by a top wall (212), a bottom wall (214), a front wall (216), a rear wall (218), a first side wall (220), and a second side wall (222) A rotatably removable lid (0) is 5 inte.pi.orly mounted with a scoop (32) and is pivotally hinged to a collar (300) that includes a sealing gasket (330) The collar (300) mounts to the walls of the container (210) A sealing wall 240 of the lid (0) cooperates with the gasket 300 to prevent the contents from spilling The container (210) incorporates powder control features, a container wall junction (50) preferred geometry and congruent 10 scoop (32) enabling convenient access to the contents, a tolerance vanation accommodating and strength improving, J-shaped collar (300) and interlocking indentations (290) and flex clips (310)
Patent CA-2674860-A1 (CA)
Title: Illuminated point of sale signage system
Inventor: MARINAKIS DIMITRIOS
IPC: G09F13/00
Filed: 2009-08-07
Abstract: An illuminated point of sale sign is disclosed which includes a frame, a lighting system and a battery electrically connected to the lighting system, the lighting system and the battery being disposed within the frame, and a light sensor disposed outside the frame and electrically connected to the lighting system and the battery.  The frame includes projections which define inner grooves adapted to receive and accommodate existing real estate signs made of thin corrugated plastic or lexan.
Patent CA-2675204-A1 (CA)
Inventor: LO FREDERICK Y
IPC: B01J29/70
Filed: 2007-12-20
Abstract: This disclosure relates to a catalyst composition (a) a crystalline MCM-22 molecular sieve; and (b) a binder comprising at least 1 wt. % of a titanium compound. In one aspect of this disclosure, the titanium compound comprises at least one of titanium oxide, titanium hydroxide, titanium sulfate, titanium phosphate, or any combination thereof. In another aspect of this disclosure, the catalyst composition further comprises a crystalline MCM-22 family molecular sieve comprising at least one of MCM-22, MCM-36, MCM-49, MCM-56, ITQ-I, ITQ-2, ITQ-30, PSH-3, ERB-I, SSZ-25, or any combination thereof. In other embodiments, this disclosure relates to a process for preparing the catalyst composition of this disclosure, the process comprises (a) providing the crystalline MCM-22 family molecular sieve and the binder comprising at least 1 wt.% of a titanium compound to form a mixture; and (b) forming the mixture into the catalyst composition. In a preferred embodiment, the forming step comprises extruding. In yet other embodiments, this disclosure discloses a process for alkylating an aromatic hydrocarbon with an alkylating agent to produce an alkylated aromatic product by contacting the aromatic hydrocarbon and alkylating agent with the catalyst composition.
Patent CA-2679943-A1 (CA)
Title: Multigene assay to predict outcome in an individual with glioblastoma
Inventor: COLMAN HOWARD
IPC: G01N33/574
Filed: 2008-02-29
Abstract: The present invention concerns prognosis for glioblastoma and/or assessment of the response of an individual to therapy for glioblastoma treatment. In particular, expression analysis of two or more specific genes provided in the invention is determined to predict outcome for the individual and/or to predict if the individual will respond to therapy, such as chemoradiation, for example. In specific embodiments, a multigene set from a sample from the individual is compared to a reference set of housekeeping genes. fold-change
Patent CA-2682507-A1 (CA)
Inventor: ATALA ANTHONY
IPC: A61K38/19
Filed: 2008-04-08
Abstract: A method of treating hypoxic tissue such as wound tissue comprises contacting a composition to the hypoxic tissue in a hypoxia-treatment effective amount, the composition comprising a biodegradable polymer and an inorganic peroxide incorporated into the polymer.
Patent CA-2682678-A1 (CA)
Inventor: HARVIE BRUCE
IPC: A61M1/00
Filed: 2008-04-02
Abstract: Assemblies in accordance with the invention can lead to an exceptionally easy to use, safe, and convenient system and method of applying a fixed dosage of chemicals to which a user might wish to avoid contact, such as parasiticides. In the present invention, a fluid, such as a pesticide or parasiticide, glue, solvent, lubricant, medicament and the like is loaded into a fluid reservoir and the reservoir sealed. The reservoir can be attached to a cap-applicator structure which is in an inactive configuration. In the inactive configuration, a piercing tip remains poised over the reservoir in an inactive configuration without forming an opening in the reservoir. The cap- applicator can have a sharp intsernal piercing tip capable of piercing the reservoir when the assembly is converted into an active configuration. This will allow the user to dispense the liquid out of the reservoir through the applicator.
Patent CA-2684727-A1 (CA)
Title: Utilisation d'une temperature basse et/ou d'un ph bas dans une culture cellulaire
Inventor: HILLER GREGORY WALTER
IPC: C12P21/02
Filed: 2008-04-22
Abstract: La présente invention concerne un nouveau procédé destiné à réduire le mauvais repliement et l'agrégation des protéines dans une culture cellulaire, en cultivant la culture cellulaire dans des conditions de température réduite et/ou de pH réduit. Il s'ensuit que la qualité de la protéine produite par culture cellulaire est considérablement améliorée. Par conséquent, la présente invention permet d'améliorer l'efficacité des protéines thérapeutique produites par culture cellulaire.
Patent CA-2684878-A1 (CA)
Title: Provision of new cardiomyocyte progenitor cells and cardiomyocytes derived therefrom
Inventor: DOEVENDANS PIETER
IPC: A61K35/34
Filed: 2008-01-09
Abstract: The present invention relates to cardiomyocyte progenitor cells (CMPCs), to methods for their isolation and to the use of this CMPCs for the provision of cardiomyocytes, by way of differentiating the obtained CMPCs with a demethylating agent. The present invention also relates to pharmaceuticals compositions comprising cardiomyocytes for use in a cardiomyocyte replacement therapy and/or for the treatment in myocardial infarctation or for ameliorating the effects of myocardial infarctation.
Patent CA-2684941-A1 (CA)
Title: Improvements in or relating to beverage preparation machines
Inventor: HALLIDAY ANDREW MICHAEL
IPC: A47J31/06
Filed: 2008-05-16
Abstract: The present invention provides a delivery head for a beverage preparation machine comprising a movable first part and a fixed second part, the first part being movable relative to the second part between an open position and a closed position, in the open position the first part being positioned to enable loading of a cartridge into the delivery head, in the closed position the first part and second part being positioned to hold said cartridge in a dispensing position, the delivery head further comprising an inlet piercer and an outlet piercer, the inlet piercer and the outlet piercer bein g orientated substantially in the same direction and being pivotable relative to the fixed second part between a retracted position and a piercing position.
Patent CA-2685462-A1 (CA)
Inventor: SAWAHASHI MAMORU
IPC: H04B7/26
Filed: 2008-04-28
Abstract: A base station device which performs communication by transmitting an L1/L2 control channel to a user device can use a combination of a modulation method and a channel encoding method including a plurality of types of encoding ratios. The user device reports downlink feedback information. The base station device includes: means for collecting the downlink feedback information; means for calculating a statistic amount according to the collected feedback information; means for judging whether the cell covered by the local base station device is an isolated cell or a cellular cell according to the obtained statistic amount; and means for setting a combination of a modulation method and a channel encoding method to be applied to the L1/L2 control channel according to the judgment result.
Patent CA-2687401-A1 (CA)
Title: Procede de realisation d'un dispositif comportant une antenne de transpondeur connectee a des plages de contact et dispositif obtenu
Inventor: ROUSSEL FRANCOIS
IPC: H01Q1/22
Filed: 2008-05-13
Abstract: L'invention concerne un procédé de réalisation dispositif comportant une antenne de transpondeur connectée à des plages de contact, ledit procédé com portant des étapes de: fourniture ou réalisation d'une antenne (3) comportan t des portions terminales (7b, 8b) de connexion reposant sur un substrat, - report des plages de contact (5, 6) sur le substrat et leur connexion aux po rtions terminales de l'antenne (7b, 8b) la connexion étant réalisée sous for me d'une soudure (38) par apport d'énergie entre les plages (5, 6) et les po rtions terminales (7b, 8b); Le procédé se distingue en ce que les plages (5, 6) sont reportées de manière à présenter une surface (40) en regard d'une p ortion terminale (7b, 8b) de connexion de l'antenne, ladite portion étant di sposée sur le substrat (2, 2b, 2f ), l'énergie de soudure étant appliquée di rectement sur les plages (5, 6). L'invention concerne également le dispositi f obtenu.
Patent CA-2688078-A1 (CA)
Inventor: CROSBY WILLETTE D
IPC: C08J7/046
Filed: 2007-06-06
Abstract: [0051] Substrates prone to heat distortion may be coated with a coating composition containing chlorinated poly olefin- modified acrylic latex emulsion, polyurethane dispersion, non-gelling self-crosslinking acrylic emulsion, and glycol-based solvent. The coating composition contains sufficient non-gelling self-crosslinking acrylic emulsion and glycol-based solvent so that a 0.1 mm wet thickness layer of the coating composition will form a tack-free film when heated at 65° C for fifteen minutes, and the glycol-based solvent is selected so that the coating composition is shelf stable,
Patent CA-2688661-A1 (CA)
Inventor: JACOB LUDWIG MANFRED
IPC: A23L33/00
Filed: 2009-12-16
Abstract: The invention relates to polyphenol-rich products of plants and also to a method of producing these products. In addition, the invention relates to the use of the polyphenol-containing products for producing foods, food supplements, dietetic foods and cosmetics;  and also foods, food supplements, dietetic foods and cosmetics which contain such a product.
Patent CA-2688744-A1 (CA)
Title: A method and apparatus for a self-service kiosk system for collecting and reporting blood alcohol level
Inventor: WILLIAMS BARRY
IPC: G06Q50/00
Filed: 2007-12-13
Abstract: A method and an apparatus is provided for a self-service breathalyzer kiosk system for collecting and reporting blood alcohol level information. The system and method enables a user to submit a report containing the user's current blood alcohol level at the time the report is submitted. In particular, the kiosk may be used to collect the current blood alcohol level information of the user and transmit the report of the current blood alcohol level information of the user over a communication network.